TRANSMEDICS GROUP INC (TMDX) Stock Fundamental Analysis
USA - NASDAQ:TMDX - US89377M1099 - Common Stock
115.68 USD
+3.07 (+2.73%)
110.3 USD
-5.38 (-4.65%)
Overall TMDX gets a fundamental rating of 6 out of 10. We evaluated TMDX against 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of TMDX get a neutral evaluation. Nothing too spectacular is happening here. TMDX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make TMDX suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year TMDX was profitable.
TMDX had a positive operating cash flow in the past year.
TMDX had negative earnings in 4 of the past 5 years.
TMDX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 8.05%, TMDX belongs to the best of the industry, outperforming 91.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.53%, TMDX belongs to the top of the industry, outperforming 94.76% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.25%, TMDX belongs to the top of the industry, outperforming 83.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROIC | 7.25% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TMDX's Profit Margin of 13.49% is amongst the best of the industry. TMDX outperforms 90.05% of its industry peers.
TMDX's Operating Margin of 14.41% is amongst the best of the industry. TMDX outperforms 84.29% of its industry peers.
TMDX has a Gross Margin (59.79%) which is in line with its industry peers.
TMDX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMDX is destroying value.
The number of shares outstanding for TMDX has been increased compared to 1 year ago.
Compared to 5 years ago, TMDX has more shares outstanding
TMDX has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.05 indicates that TMDX is not in any danger for bankruptcy at the moment.
TMDX has a Altman-Z score of 5.05. This is amongst the best in the industry. TMDX outperforms 80.63% of its industry peers.
The Debt to FCF ratio of TMDX is 29.44, which is on the high side as it means it would take TMDX, 29.44 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 29.44, TMDX is doing good in the industry, outperforming 68.59% of the companies in the same industry.
TMDX has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of TMDX (1.61) is worse than 81.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Altman-Z | 5.05 |
ROIC/WACC0.92
WACC7.9%
2.3 Liquidity
A Current Ratio of 9.86 indicates that TMDX has no problem at all paying its short term obligations.
TMDX has a better Current ratio (9.86) than 92.67% of its industry peers.
A Quick Ratio of 9.10 indicates that TMDX has no problem at all paying its short term obligations.
TMDX has a Quick ratio of 9.10. This is amongst the best in the industry. TMDX outperforms 92.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 4725.00% over the past year.
Looking at the last year, TMDX shows a very strong growth in Revenue. The Revenue has grown by 48.09%.
The Revenue has been growing by 79.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
3.2 Future
TMDX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.56% yearly.
The Revenue is expected to grow by 21.19% on average over the next years. This is a very strong growth
EPS Next Y139.14%
EPS Next 2Y66.51%
EPS Next 3Y53.26%
EPS Next 5Y42.56%
Revenue Next Year39.68%
Revenue Next 2Y29.84%
Revenue Next 3Y25.77%
Revenue Next 5Y21.19%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
TMDX is valuated quite expensively with a Price/Earnings ratio of 59.94.
TMDX's Price/Earnings ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 67.02% of the companies in the same industry.
When comparing the Price/Earnings ratio of TMDX to the average of the S&P500 Index (27.29), we can say TMDX is valued expensively.
TMDX is valuated quite expensively with a Price/Forward Earnings ratio of 41.31.
Based on the Price/Forward Earnings ratio, TMDX is valued a bit cheaper than the industry average as 70.68% of the companies are valued more expensively.
TMDX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.85, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.94 | ||
| Fwd PE | 41.31 |
4.2 Price Multiples
68.59% of the companies in the same industry are more expensive than TMDX, based on the Enterprise Value to EBITDA ratio.
TMDX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 67.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 227.27 | ||
| EV/EBITDA | 40.42 |
4.3 Compensation for Growth
TMDX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TMDX's earnings are expected to grow with 53.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y66.51%
EPS Next 3Y53.26%
5. Dividend
5.1 Amount
No dividends for TMDX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.68
+3.07 (+2.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners111.43%
Inst Owner Change0.03%
Ins Owners2.96%
Ins Owner Change2.28%
Market Cap3.94B
Analysts81.11
Price Target149.43 (29.18%)
Short Float %25.39%
Short Ratio7.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.71%
Min EPS beat(2)100.04%
Max EPS beat(2)167.38%
EPS beat(4)3
Avg EPS beat(4)55.99%
Min EPS beat(4)-59.86%
Max EPS beat(4)167.38%
EPS beat(8)6
Avg EPS beat(8)145.25%
EPS beat(12)10
Avg EPS beat(12)114.95%
EPS beat(16)11
Avg EPS beat(16)83.13%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.34%
Max Revenue beat(2)13.8%
Revenue beat(4)3
Avg Revenue beat(4)4.75%
Min Revenue beat(4)-7.28%
Max Revenue beat(4)13.8%
Revenue beat(8)7
Avg Revenue beat(8)11.77%
Revenue beat(12)11
Avg Revenue beat(12)15.17%
Revenue beat(16)14
Avg Revenue beat(16)17.24%
PT rev (1m)-2.98%
PT rev (3m)5.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.11%
EPS NY rev (1m)0.39%
EPS NY rev (3m)31.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.85%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)3.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.94 | ||
| Fwd PE | 41.31 | ||
| P/S | 7.42 | ||
| P/FCF | 227.27 | ||
| P/OCF | 34.21 | ||
| P/B | 12.4 | ||
| P/tB | 12.95 | ||
| EV/EBITDA | 40.42 |
EPS(TTM)1.93
EY1.67%
EPS(NY)2.8
Fwd EY2.42%
FCF(TTM)0.51
FCFY0.44%
OCF(TTM)3.38
OCFY2.92%
SpS15.58
BVpS9.33
TBVpS8.93
PEG (NY)0.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROCE | 9.18% | ||
| ROIC | 7.25% | ||
| ROICexc | 13.96% | ||
| ROICexgc | 14.41% | ||
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% | ||
| FCFM | 3.27% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Debt/EBITDA | 5.09 | ||
| Cap/Depr | 412.74% | ||
| Cap/Sales | 18.43% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 114.93% | ||
| Profit Quality | 24.21% | ||
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 | ||
| Altman-Z | 5.05 |
F-Score7
WACC7.9%
ROIC/WACC0.92
Cap/Depr(3y)951.97%
Cap/Depr(5y)615.69%
Cap/Sales(3y)34.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
EPS Next Y139.14%
EPS Next 2Y66.51%
EPS Next 3Y53.26%
EPS Next 5Y42.56%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
Revenue Next Year39.68%
Revenue Next 2Y29.84%
Revenue Next 3Y25.77%
Revenue Next 5Y21.19%
EBIT growth 1Y6324.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.7%
EBIT Next 3Y89.1%
EBIT Next 5Y68.38%
FCF growth 1Y142.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y451.66%
OCF growth 3YN/A
OCF growth 5YN/A